{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:42:05Z","timestamp":1792424525690,"version":"4.5.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To evaluate the influence of pessary visit intervals on development of vaginal epithelial abnormalities.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>We conducted a randomized, noninferiority trial of office-based pessary care. Eligible participants were adult women wearing a ring, Gellhorn, or incontinence dish pessary to treat pelvic organ prolapse or incontinence or both. Patients were randomized 1:1 to routine pessary care (office visits every 12 weeks, \u201croutine\u201d arm) or to extended pessary care (office visits every 24 weeks, \u201cextended\u201d arm). The primary study outcome was rate of vaginal epithelial abnormalities (epithelial break or erosion) at the final study visit (48 weeks). The predetermined noninferiority margin was 7.5%.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>From January 2015 through June 2017, inclusive, 448 patients were screened and 130 were randomized, 64 to the routine arm and 66 to the extended arm. Baseline characteristics of the study arms were similar with the exception of pessary type, with ring pessary more common in the routine arm and Gellhorn pessary more common in the extended arm (<jats:italic toggle=\"yes\">P<\/jats:italic>=.02). The rate of epithelial abnormalities at the final study visit (48 weeks) was 7.4% in the routine arm and 1.7% in the extended arm (difference, \u22125.7 percentage points; 95% CI \u22127.4 to \u22124), which met the criterion for noninferiority. Rates of all types of epithelial abnormalities did not differ between arms at any time point. Increasing duration of pessary use (<jats:italic toggle=\"yes\">P<\/jats:italic>=.003) and history of prior epithelial abnormalities were associated with development of epithelial abnormalities (<jats:italic toggle=\"yes\">P<\/jats:italic>=.01). Other than epithelial abnormalities, no adverse events related to pessary use occurred in either arm.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>In women who receive office-based pessary care and are using a ring, Gellhorn, or incontinence dish pessary, routine follow-up every 24 weeks is noninferior to every 12 weeks based on incidence of vaginal epithelial abnormalities.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CLINICAL TRIAL REGISTRATION:<\/jats:title>\n            <jats:p>\n                                 ClinicalTrials.gov, NCT02371083.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000003580","type":"journal-article","created":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T19:51:58Z","timestamp":1575661918000},"page":"100-105","source":"Crossref","is-referenced-by-count":40,"title":["Timing of Office-Based Pessary Care"],"prefix":"10.1097","volume":"135","author":[{"given":"Katie","family":"Propst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Mellen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"O'Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul K.","family":"Tulikangas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,12,3]]},"reference":[{"key":"R1-20230711","first-page":"931","article-title":"A survey of pessary use by members of the American urogynecologic society","volume":"95","author":"Cundiff","year":"2000","journal-title":"Obstet Gynecol"},{"key":"R2-20230711","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jmig.2010.09.006","article-title":"Use of a pessary in treatment of pelvic organ prolapse: quality of life, compliance, and failure at 1-year follow-up","volume":"18","author":"Ko","year":"2011","journal-title":"J Minim Invasive Gynecol"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/SPV.0b013e31823a8186","article-title":"Pessary use and impact on quality of life and body image","volume":"17","author":"Patel","year":"2011","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.ajog.2007.08.013","article-title":"Pelvic floor symptom changes in pessary users","volume":"197","author":"Komesu","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/SPV.0000000000000060","article-title":"The impact of pessary use on bowel symptoms: one-year outcomes","volume":"20","author":"Brazell","year":"2014","journal-title":"Female Pelvic Med Reconstr"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.ajog.2003.10.711","article-title":"Patient satisfaction and changes in prolapse and urinary symptoms in women who were fitted successfully with a pessary for pelvic organ prolapse","volume":"190","author":"Clemons","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00192-014-2329-6","article-title":"How often should shelf\/Gellhorn pessaries be changed? A survey of IUGA urogynaecologists","volume":"25","author":"Khaja","year":"2014","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/01443610902719813","article-title":"Evaluation of vaginal pessary management: a UK-based survey","volume":"29","author":"Gorti","year":"2009","journal-title":"J Obstet Gynaecol"},{"key":"R9-20230711","first-page":"205","article-title":"Gynecologists' patterns of prescribing pessaries","volume":"46","author":"Pott-Grinstein","year":"2001","journal-title":"J Reprod Med"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"E400","DOI":"10.5489\/cuaj.2783","article-title":"An integrative review and severity classification of complications related to pessary use in the treatment of female pelvic organ prolapse","volume":"9","author":"Abdulaziz","year":"2015","journal-title":"Can Urol Assoc J"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/AOG.0b013e3181d9d421","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials","volume":"115","author":"Schulz","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0002-9378(96)70243-0","article-title":"The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction","volume":"175","author":"Bump","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/AOG.0b013e31824c0806","article-title":"Nonsurgical management of pelvic organ prolapse","volume":"119","author":"Culligan","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R14-20230711","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00192-008-0574-2","article-title":"Complications of neglected vaginal pessaries: case presentation and literature review","volume":"19","author":"Arias","year":"2008","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"R15-20230711","first-page":"757","article-title":"Effect of local estrogen cream on vaginal health after pessary use for prolapsed pelvic organ: a randomized controlled trial","volume":"99","author":"Tontivuthikul","year":"2016","journal-title":"J Med Assoc Thail"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s00192-016-3000-1","article-title":"Effect of vaginal estrogen on pessary use [published erratum appears in Int Urogynecol J Pelvic Floor Dysfunct 2019;27:1431]","volume":"27","author":"Dessie","year":"2016","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"R17-20230711","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/2053369115614704","article-title":"Does vaginal estrogen treatment with support pessaries in vaginal prolapse reduce complications?","volume":"21","author":"Bulchandani","year":"2015","journal-title":"Post Reprod Heal"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000003580","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T19:44:36Z","timestamp":1689104676000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000003580"}},"subtitle":["A Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2019,12,3]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000003580","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12,3]]}}}